Kyntra Bio, Inc. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Kyntra Bio, Inc. (KYNB) is -21902405.00

According to Kyntra Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -21902405.00. This represents a change of 24.87% compared to the average of -17540350.00 of the last 4 quarters.

Kyntra Bio, Inc. (KYNB) Historical Enterprise Value (quarterly & annually)

How has KYNB Enterprise Value performed in the past?

The mean historical Enterprise Value of Kyntra Bio, Inc. over the last ten years is 1.73B. The current -21902405.00 Enterprise Value has changed -226.94% with respect to the historical average. Over the past ten years (40 quarters), KYNB's Enterprise Value was at its highest in in the March 2019 quarter at 4.74B. The Enterprise Value was at its lowest in in the September 2025 quarter at -47396000.00.

Kyntra Bio, Inc. (KYNB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kyntra Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kyntra Bio, Inc. (KYNB) Average Enterprise Value

How has KYNB Enterprise Value performed in the past?

The current Enterprise Value of Kyntra Bio, Inc. (KYNB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kyntra Bio, Inc. (KYNB) Enterprise Value vs. Peers

How is KYNB’s Enterprise Value compared to its peers?

Kyntra Bio, Inc.’s Enterprise Value is less than Kezar Life Sciences, Inc. (-11018667.00), less than Tempest Therapeutics, Inc. (21.08M), less than Aligos Therapeutics, Inc. (5.12M), greater than OnKure Therapeutics, Inc. (-45706952.00), less than Mersana Therapeutics, Inc. (91.27M), less than X4 Pharmaceuticals, Inc. (212.25M), less than PDS Biotechnology Corporation (45.86M), less than Celularity Inc. (71.49M), greater than Xilio Therapeutics, Inc. (-70297743.00), less than Actinium Pharmaceuticals, Inc. (2.20M),

Build a custom stock screener for Kyntra Bio, Inc. (KYNB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kyntra Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kyntra Bio, Inc. (KYNB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kyntra Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.